Sumatriptan has been in use for the treatment of acute migraine headache for almost 2 decades. Initially, sumatriptan was available only in an injectable formulation; using an “autoinjector” specifically designed for the drug, sumatriptan can be delivered subcutaneously (just below the skin surface) via a small needle.
This report contains market size and forecasts of Sumatriptan Autoinjector in global, including the following market information:
Global Sumatriptan Autoinjector Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sumatriptan Autoinjector Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Sumatriptan Autoinjector companies in 2021 (%)
The global Sumatriptan Autoinjector market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
4mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sumatriptan Autoinjector include GlaxoSmithKline, Pfizer, Teva and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sumatriptan Autoinjector manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sumatriptan Autoinjector Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sumatriptan Autoinjector Market Segment Percentages, by Type, 2021 (%)
4mg
6mg
Others
Global Sumatriptan Autoinjector Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sumatriptan Autoinjector Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Sumatriptan Autoinjector Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sumatriptan Autoinjector Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sumatriptan Autoinjector revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sumatriptan Autoinjector revenues share in global market, 2021 (%)
Key companies Sumatriptan Autoinjector sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Sumatriptan Autoinjector sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Pfizer
Teva
Sun Pharma